Brain Trust Accelerator Fund
VC Fund
Burlingame, United States
Brain Trust Accelerator Fund is a VC fund in Burlingame focused on Health Care and Pharmaceutical. The Brain Trust Accelerator Fund focuses on early stage investments that address the diagnosis and treatment of brain related diseases.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Brain Trust Accelerator Fund invests in
Stages Brain Trust Accelerator Fund invests in
Countries Brain Trust Accelerator Fund invests in
Investment Focus
Industry
- Health Care 3 (50%)
- Pharmaceutical 3 (50%)
- Therapeutics 2 (33%)
- Apps 1 (17%)
- Beauty 1 (17%)
Stage
- Series B 3 (50%)
- Seed 1 (17%)
- Series A 1 (17%)
- Funding Round 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Neuro Therapia
|
NeuroTherpia, Inc., founded in 2015 by Drs. Mohamed Naguib and Joseph Foss, is developing new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) has been shown to decrease activation of microglial cells in the brain.Decreasing activation of these cells leads to decreased inflammation and decreased injury to surrounding nerve cells. Decreasing this inflammation can treat and even prevent the development of neuropathic pain in settings of nerve injury or chemotherapy. Recent work has shown that blocking this inflammation is also important in reversing the effects seen in Alzheimer's disease. We are currently doing preclinical safety studies and plan on studying NTRX-07 in humans in 2016. | $12.3M / Series B / Aug 06, 2024 | |
MyAvana
|
MyAvana, formerly known as Madame You, provides hair care recommendation system, combining artificial intelligence and hair care experts to support and guide women with their hair care. It offers a hair analysis service to recommend the best hair products and styling techniques for your unique hair type and texture. | Jan 11, 2024 | |
|
MyAvana
|
MyAvana, formerly known as Madame You, provides hair care recommendation system, combining artificial intelligence and hair care experts to support and guide women with their hair care. It offers a hair analysis service to recommend the best hair products and styling techniques for your unique hair type and texture. | Seed / Jan 10, 2024 | |
Chase Therapeutics
|
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease. | $20M / Series B / Oct 20, 2021 | |
|
Neuro Therapia
|
NeuroTherpia, Inc., founded in 2015 by Drs. Mohamed Naguib and Joseph Foss, is developing new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) has been shown to decrease activation of microglial cells in the brain.Decreasing activation of these cells leads to decreased inflammation and decreased injury to surrounding nerve cells. Decreasing this inflammation can treat and even prevent the development of neuropathic pain in settings of nerve injury or chemotherapy. Recent work has shown that blocking this inflammation is also important in reversing the effects seen in Alzheimer's disease. We are currently doing preclinical safety studies and plan on studying NTRX-07 in humans in 2016. | $8.8M / Series A / Sep 22, 2020 | |
Satoris
|
Satoris develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. They're committed to developing and commercializing neurodiagnostic tests that yield the earliest, most accurate, and most clinically relevant diagnoses, so that healthcare costs can be reduced while patientcare becomes even more effective. | $5.2M / Series B / Mar 25, 2008 |
Co-Investors
Cleveland Clinic
3 deals together
Alzheimer's Drug Discovery Foundation
2 deals together
Dolby Family Ventures
2 deals together
Prisma Ventures
2 deals together
CRUINT
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Brain Trust Accelerator Fund invest in?
Brain Trust Accelerator Fund invests primarily in Health Care, Pharmaceutical and Therapeutics startups, most often at Series B and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Brain Trust Accelerator Fund last invest?
The most recent investment recorded for Brain Trust Accelerator Fund closed in Aug 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
